Literature DB >> 11797086

Expression of neuregulin and ErbB3 and ErbB4 after a traumatic lesion in the ventral funiculus of the spinal cord and in the intact primary olfactory system.

T Lindholm1, S Cullheim, M Deckner, T Carlstedt, M Risling.   

Abstract

Neuron-derived neuregulins have been implicated in the regulation of glial cell function and survival. This factor family and its receptors may therefore be assumed to be of importance for the cellular response to traumatic injury. In this study we have examined the distribution of mRNA for neuregulin 1 (NRG1), ErbB3 and ErbB4-receptor tyrosine kinases after a ventral funiculus lesion in the lumbar spinal cord (VFL). The techniques used were in situ hybridization and immunohistochemistry. The survival times were 1-21 days. The spinal cords from normal adult and embryonic rats were used as controls. For comparison, sections from the olfactory bulb of perinatal and adult rats were also included in the study. Expression of NRG1 mRNA was observed in motoneurons in the intact spinal cord. A decrease in the labeling for NRG1 mRNA was seen during the first 5 days after VFL but then became slightly upregulated at 3 weeks after the lesion. A high labeling signal for ErbB3-mRNA was observed in the ventral and dorsal roots of E16 and E18 embryos. Labeling for ErbB3-mRNA was strong in the affected ventral root at 3 days after the VFL, reached a maximum at 1 week and was still upregulated after 3 weeks. Increased labeling for ErbB3 was also noted in scattered cells in the scar tissue 1-3 weeks after the VFL. These findings were verified with immunohistochemistry for ErbB3. A strong labeling for ErbB3 in the olfactory nerve fiber layer and olfactory nerve bundles was observed in rats of all ages examined. ErbB4 had strong expression in the embryonic spinal cord, but no evidence for lesion-induced regulation of ErbB4 receptors could be found after the VFL. Our data show that ErbB3 in the ventral roots was upregulated after a VFL and that NRG1 mRNA was initially downregulated in the motoneurons. The lesion-induced changes in the expression of NRG1 and ErbB3 in the injured spinal cord and denervated ventral root can be assumed to be of importance for axonal growth and the regulation of glial cell survival.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11797086     DOI: 10.1007/s00221-001-0922-7

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  9 in total

1.  Neuregulin-1 at synapses on phrenic motoneurons.

Authors:  Amine N Issa; Wen-Zhi Zhan; Gary C Sieck; Carlos B Mantilla
Journal:  J Comp Neurol       Date:  2010-10-15       Impact factor: 3.215

2.  Age and Sex-Related Changes to Gene Expression in the Mouse Spinal Cord.

Authors:  Jeremy McCallum-Loudeac; Greg Anderson; Megan J Wilson
Journal:  J Mol Neurosci       Date:  2019-07-02       Impact factor: 3.444

Review 3.  Linking vascular disorders and Alzheimer's disease: potential involvement of BACE1.

Authors:  Sarah L Cole; Robert Vassar
Journal:  Neurobiol Aging       Date:  2008-03-04       Impact factor: 4.673

Review 4.  The ERBB3 receptor in cancer and cancer gene therapy.

Authors:  G Sithanandam; L M Anderson
Journal:  Cancer Gene Ther       Date:  2008-04-11       Impact factor: 5.987

5.  On acute gene expression changes after ventral root replantation.

Authors:  Marten Risling; Thomas Ochsman; Thomas Carlstedt; Hans Lindå; Stefan Plantman; Elham Rostami; Maria Angeria; Mattias K Sköld
Journal:  Front Neurol       Date:  2011-01-04       Impact factor: 4.003

6.  Identification of pivotal genes and pathways for spinal cord injury via bioinformatics analysis.

Authors:  Zonghao Zhu; Qiang Shen; Liang Zhu; Xiaokang Wei
Journal:  Mol Med Rep       Date:  2017-07-21       Impact factor: 2.952

7.  The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimer's Disease.

Authors:  S L Cole; R Vassar
Journal:  Curr Genomics       Date:  2007-12       Impact factor: 2.236

8.  The Alzheimer's disease beta-secretase enzyme, BACE1.

Authors:  Sarah L Cole; Robert Vassar
Journal:  Mol Neurodegener       Date:  2007-11-15       Impact factor: 14.195

9.  Neuroprotection and immunomodulation following intraspinal axotomy of motoneurons by treatment with adult mesenchymal stem cells.

Authors:  A B Spejo; G B Chiarotto; A D F Ferreira; D A Gomes; R S Ferreira; B Barraviera; A L R Oliveira
Journal:  J Neuroinflammation       Date:  2018-08-14       Impact factor: 8.322

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.